News from endo international plc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 06, 2019, 07:30 ET Nationally Recognized Urologist and Author, Aaron Spitz, MD, Teams Up with Endo Pharmaceuticals' Ask About the Curve Campaign to Encourage Men to Get "In Touch" With Their Anatomy This Men's Health

Ask About the Curve raises awareness of Peyronie's disease, a men's health condition that may affect about 1 in 10 men and leads to a pronounced curvature in the penis and potential pain during...


May 17, 2019, 07:00 ET Phase 3 Data of Collagenase Clostridium Histolyticum for the Investigational Treatment of Cellulite to Be Presented at The Aesthetic Meeting 2019

Endo International plc (NASDAQ: ENDP) today announced that clinical data from a Phase 3 investigational study of collagenase clostridium histolyticum (CCH) for the treatment of cellulite will be...


May 15, 2019, 17:00 ET Endo to Participate at RBC Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the RBC Annual Healthcare Conference in New York City on Tuesday, May 21, 2019...


May 09, 2019, 06:30 ET Endo Reports First-Quarter 2019 Financial Results

First-quarter 2019 revenues increased 3 percent to $720 million compared to first-quarter 2018 revenues of $701 million First-quarter 2019 Sterile Injectables revenues increased 25 percent to $270...


May 01, 2019, 17:35 ET Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall of One Lot of Mycophenolate Mofetil for Injection, USP Due to the Presence of a Glass Fragment Observed in One Vial of Reconstituted Product

Endo International plc, announced today that one of its operating companies, Par Pharmaceutical, Inc., is voluntarily recalling one lot of Mycophenolate Mofetil for Injection, USP to the hospital and ...


Apr 10, 2019, 17:00 ET Endo to Announce First-Quarter 2019 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2019 financial results on May 9, 2019 and members of its senior management team will host a conference call and webcast at 7:30 a....


Apr 05, 2019, 07:30 ET Endo Begins Shipment of Authorized Generic Version of PROVENTIL® (albuterol sulfate) HFA Inhalation Aerosol in the United States

Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Merck's PROVENTIL® (albuterol...


Mar 27, 2019, 21:11 ET Endo International plc Announces Early Tender Results of its Previously Announced Cash Tender Offers and Consent Solicitations for up to $1.5 billion Aggregate Purchase Price of its Outstanding

Endo International plc (NASDAQ: ENDP) (the "Company" or "Endo") today announced the early tender results of the previously announced cash tender offers (the "Tender Offers") made by Endo Finance LLC...


Mar 19, 2019, 07:30 ET Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery

Endo International plc (NASDAQ: ENDP) today announced the publication of Phase 2 data evaluating collagenase clostridium histolyticum (or "CCH") for the treatment of cellulite in Dermatologic...


Mar 14, 2019, 20:06 ET Endo International plc Announces Pricing of Private Offering Of Senior Secured Notes

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc. (the "Issuer"), its wholly-owned subsidiary, priced $1.5 billion aggregate principal amount of 7.500%...


Mar 14, 2019, 20:06 ET Endo International plc Announces an Upsizing of its Cash Tender Offers and Consent Solicitations

Endo International plc (NASDAQ: ENDP) today announced an upsizing of its previously announced cash tender offers (the "Tender Offers") and consent solicitations by Endo Finance LLC ("Endo Finance"),...


Mar 14, 2019, 07:54 ET Endo International plc Announces Debt Refinancing Transactions, Including Cash Tender Offers and Consent Solicitations for up to $1.0 billion Aggregate Purchase Price of its Outstanding Senior Notes

Endo International plc (NASDAQ: ENDP) today announced a series of debt refinancing transactions that are intended to help manage the debt maturity profile of it and certain of its subsidiaries...


Mar 14, 2019, 07:51 ET Endo International plc Announces Proposed Private Offering Of Senior Secured Notes

Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc. (the "Issuer"), its wholly-owned subsidiary, intends to offer senior secured notes, subject to market and...


Mar 04, 2019, 08:00 ET Endo to Participate at Cowen & Company 39th Annual Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Cowen & Company 39th Annual Healthcare Conference in Boston, Massachusetts...


Mar 01, 2019, 15:27 ET Endo Announces FDA Decision Not to Include Vasopressin on 503B Bulks List

Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.S. Food and Drug Administration (FDA) has determined that there is no clinical need to compound vasopressin under Section...


Mar 01, 2019, 07:30 ET Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that it will present new data showing collagenase clostridium histolyticum (CCH) significantly met the clinical endpoint of improved cellulite...


Feb 28, 2019, 06:30 ET Endo Reports Fourth-Quarter And Full Year 2018 Financial Results

Fourth-quarter 2018 revenues increased 2 percent to $786 million Fourth-quarter 2018 Sterile Injectables revenues increased 32 percent to $259 million Fourth-quarter 2018 XIAFLEX® franchise revenues...


Feb 27, 2019, 17:15 ET Endo Announces Termination of Acquisition Agreements with Somerset Therapeutics and Business of Affiliate Wintac Limited

Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Endo Ventures Limited, Par Pharmaceutical, Inc. and Par Formulations Private Limited, have terminated their respective...


Feb 22, 2019, 07:30 ET Paladin Labs Inc. Announces Approval of Envarsus PA™ (tacrolimus prolonged-release tablets) in Canada

Paladin Labs Inc. and Endo Ventures Limited, subsidiaries of Endo International plc (NASDAQ: ENDP), today announced Health Canada's approval of Envarsus PA™ (tacrolimus prolonged-release tablets) for ...


Feb 07, 2019, 08:00 ET Endo Agrees Not To Oppose Additional Stay of FDA Litigation Following Restoration of Government Appropriations

Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.S. Food and Drug Administration (the "FDA") has requested a further stay of Endo's ongoing litigation against the FDA through ...


Jan 25, 2019, 17:22 ET Endo to Announce Fourth-Quarter and Full-Year 2018 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its fourth-quarter and full-year 2018 financial results on February 28, 2019 and members of its senior management team will host a conference call...


Dec 31, 2018, 07:30 ET Endo Announces Anticipated Further Stay of Compounding Litigation Due to Lapse of Government Appropriations

Endo International plc ("Endo"; NASDAQ: ENDP) today announced that, due to the ongoing federal government shutdown, the U.S. Food and Drug Administration (the "FDA") has requested a further stay of...


Dec 19, 2018, 07:30 ET Endo to Participate at J.P. Morgan Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will present at the J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 7, 2019 at 11:30 ...


Nov 28, 2018, 16:34 ET Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton,...


Nov 26, 2018, 12:55 ET Endo to Participate at Piper Jaffray Global Healthcare Conference

Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Piper Jaffray Global Healthcare Conference in New York City on Tuesday,...